Macroprolactinemia in patients with prolactinomas: Prevalence and clinical significance

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 4, 2013, Pages 201-205

  Elenkova, A ^a   Genov, N ^a   Abadzhieva, Z ^a   Kirilov, G ^a   Vasilev, V ^a   Kalinov, K ^b   Zacharieva, S ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b NEW BULGARIAN UNIVERSITY   (Bulgaria)

Author keywords

macroprolactinemia; PEG precipitation test; prolactinoma

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CAVERNOUS SINUS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE DISEASE; ETHNICITY; FEMALE; FOLLITROPIN BLOOD LEVEL; GALACTORRHEA; HUMAN; HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; MACROPROLACTINEMIA; MALE; MICROADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OLIGOMENORRHEA; OVARY FUNCTION; PRECIPITATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SECONDARY AMENORRHEA; SEX RATIO;

ADULT; CASE-CONTROL STUDIES; DOPAMINE AGONISTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; MAGNETIC RESONANCE IMAGING; MALE; OVARY; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA;

EID: 84876475106     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1333232     Document Type: Article

References (35)

1. Suh H. K., Frantz A. G. Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab: 1974; 39 928 935
2. Fraser I. S., Lun Z. G., Zhou J. P. et al. Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function. J Clin Endocrinol Metab: 1989; 69 585 592 (Pubitemid 19221231)
3. Jackson R. D., Malarkey W. B. Sequential prolactin evaluation of a "curedo" patient with recurrence of prolactinoma. Am J Med: 1987; 82 343 346
4. Olukoga A. O., Kane J. W. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf): 1999; 51 119 126 (Pubitemid 29339545)
5. Wallace I. R., Satti N., Courtney C. H. et al. Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant. J Clin Endocrinol Metab: 2010; 95 3268 3271
6. Alfonso A., Rieniets K. I., Vigersky R. A. Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia. Endocr Pract: 2006; 12 275 280
7. Can M., Guven B., Atmaca H. et al. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia. Kaohsiung J Med Sci: 2011; 27 173 176
8. Isik S., Berker D., Tutuncu Y. A. et al. Clinical and radiological findings in macroprolactinemia. Endocrine: 2012; 41 327 333
9. Lakatos G., Szucs N., Kender Z. et al. Macroprolactinemia associated with pituitary macroadenoma: treatment with quinagolide. Orv Hetil: 2010; 151 1072 1075
10. Vilar L., Naves L. A., Freitas M. C. et al. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia. Minerva Endocrinol: 2007; 32 79 86
11. Theunissen C., De Schepper J., Schiettecatte J. et al. Macroprolactinemia: clinical significance and characterization of the condition. Acta Clin Belg: 2005; 60 190 197 (Pubitemid 43339159)
12. Tamer G., Telci A., Mert M. et al. Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed. Endocrine: 2012; 41 138 143
13. Anaforoglu I., Ertorer M. E., Kozanoglu I. et al. Macroprolactinemia, like hyperprolactinemia, may promote platelet activation. Endocrine: 2010; 37 294 300
14. Gibney J., Smith T. P., McKenna T. J. The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab: 2005; 90 3927 3932 (Pubitemid 41058153)
15. Hattori N. Macroprolactinemia: a new cause of hyperprolactinemia. New Research on Autoantibodies. In: Petrelli C. T. Ed Chapter I Nova Science Publishers Inc. NewYork: 2008; 13 60
16. Leslie H., Courtney C. H., Bell P. M. et al. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab: 2001; 86 2743 2746 (Pubitemid 32545732)
17. Sanchez-Eixeres M. R., Mauri M., Alfayate R. et al. Prevalence of macroprolactin detected by Elecsys 2010. Horm Res. 2001; 56 87 92 (Pubitemid 34195732)
18. Suliman A. M., Smith T. P., Gibney J. et al. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem: 2003; 49 1504 1509 (Pubitemid 37011739)
19. Vallette-Kasic S., Morange-Ramos I., Selim A. et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab: 2002; 87 581 588 (Pubitemid 34158222)
20. Leite V., Cosby H., Sobrinho L. G. et al. Characterization of big, big prolactin in patients with hyperprolactinaemia. Clin Endocrinol (Oxf): 1992; 37 365 372
21. Sapin R., Gasser F., Grucker D. Free prolactin determinations in hyperprolactinemic men with suspicion of macroprolactinemia. Clin Chim Acta: 2002; 316 33 41 (Pubitemid 34028186)
22. Hattori N., Ishihara T., Saiki Y. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clin Endocrinol (Oxf): 2009; 71 702 708
23. Casanueva F. F., Molitch M. E., Schlechte J. A. et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf): 2006; 65 265 273 (Pubitemid 44079693)
24. Melmed S., Casanueva F. F., Hoffman A. R. et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab: 2011; 96 273 288
25. McCudden C. R., Sharpless L., Crenache D. G. Comparison of multiple methods for identification of hyperprolactinemiain the presenceo f macroprolactin. Clin Chim Acta: 2010; 411: 55 60
26. Mounier C., Trouillas J., Claustrat B. et al. Macroprolactinaemia associated with prolactin adenoma. Hum Reprod: 2003; 18 853 857 (Pubitemid 36426970)
27. Bouchard P., Lagoguey M., Brailly S. et al. Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia. J Clin Endocrinol Metab: 1985; 60 258 262 (Pubitemid 15129568)
28. Sartorio A., Pizzocaro A., Liberati D. et al. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment. Clin Endocrinol (Oxf): 2000; 52 703 712 (Pubitemid 30409262)
29. Sauder S. E., Frager M., Case G. D. et al. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine. J Clin Endocrinol Metab: 1984; 59 941 948 (Pubitemid 14020697)
30. Hattori N., Ikekubo K., Ishihara T. et al. Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody. European Journal of Endocrinology: 1994; 130 438 445 (Pubitemid 24165768)
31. Schiettecatte J., De Schepper J., Velkeniers B. et al. Rapid detection of macroprolactin in the form of prolactin-immunoglobulin G complexes by immunoprecipitation with anti-human IgG-agarose. Clin Chem Lab Med: 2001; 39 1244 1248 (Pubitemid 34026568)
32. De Schepper J., Schiettecatte J., Velkeniers B. et al. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. Eur J Endocrinol: 2003; 149 201 207 (Pubitemid 37120992)
33. Sinha Y. N. Structural variants of prolactin: occurrence and physiological significance. Endocr Rev: 1995; 16 354 369
34. Tanaka T., Yano H., Umezawa S. et al. Heterogeneity of big-big hPRL in hyperprolactinemia. Horm Metab Res: 1989; 21 84 88 (Pubitemid 19091186)
35. Ohnami S., Eto S., Soejima T. et al. Characterization of "big big prolactino" in serum and tumor extract in patients with PRL-secreting tumor. Endocrinol Jpn: 1987; 34 325 334 (Pubitemid 17137001)